A comparison of the effects of ketorolac tromethamine and dexamethasone on human osteoblasts.
Canby
F L
FL
Dossing
D A
DA
Miller
D A
DA
DiMuzio
M T
MT
D018712:Analgesics, Non-Narcotic / Q000494:pharmacology*; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D001842:Bone and Bones / Q000166:cytology; D002460:Cell Line; D002478:Cells, Cultured; D003907:Dexamethasone / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004926:Escherichia coli; D006801:Humans; D007375:Interleukin-1 / Q000032:analysis; D020911:Ketorolac Tromethamine; D008070:Lipopolysaccharides / Q000494:pharmacology; D010006:Osteoblasts / Q000187:drug effects* / Q000276:immunology; D014046:Tolmetin / Q000031:analogs & derivatives* / Q000494:pharmacology; D014325:Tromethamine / Q000031:analogs & derivatives* / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis / Q000187:drug effects
D018712:Analgesics, Non-Narcotic; D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D007375:Interleukin-1; D008070:Lipopolysaccharides; D014409:Tumor Necrosis Factor-alpha; D014325:Tromethamine; D020911:Ketorolac Tromethamine; D003907:Dexamethasone; D014046:Tolmetin